THE COMPLETE LIST OF FDA BANNED SUPPLEMENTS (2026)

Banned 2004. A plant-derived stimulant that spiked heart rate, blood pressure, and metabolism. Used in diet pills and pre-workouts. At its peak: a $1 billion/year market. At its end: 155 documented deaths, over 18,000 adverse event reports, and a 130,000-page administrative record the FDA compiled over nearly a decade just to justify the ban. A federal judge in Utah initially struck the ban down. The appeals court reinstated it in 2006. After the ban, ephedra-related poisonings dropped by over 98%. The catalyst: Baltimore Orioles pitcher Steve Bechler, 23, who died during spring training in 2003 after taking three ephedra pills. His body temperature reached 108 degrees.

Illegal since 2013. A synthetic amphetamine analogue patented by Eli Lilly in 1944, pulled from pharmaceutical use in 1983. USPlabs repackaged it as "geranium extract" and put it in Jack3d, the most popular pre-workout of its era. At least 4 deaths directly attributed (two soldiers at Fort Bliss, one marathon runner in London, one more soldier). 86 adverse event reports including cardiac arrests, strokes, and liver failure. The CEO got 5 years in federal prison. Total fines: $60 million. Read the full DMAA investigation →

Flagged 2015. A DMAA analogue that appeared in supplements immediately after DMAA was banned. Marketed as "AMP Citrate." The critical fact: zero human clinical trials have ever been conducted on DMBA. It was sold to thousands of consumers as a pre-workout stimulant despite never having been tested in a single human being.

Warning letters 2019. Originally developed in the 1950s as an inhaled bronchitis treatment — never approved for oral use. Replaced DMAA and DMBA in pre-workouts. The FDA issued nine warning letters to manufacturers in 2019. A class action lawsuit alleged "there is no difference between DMAA and DMHA" in terms of illegality. Banned by WADA. Still available.

Flagged 2015. An amphetamine isomer from the 1930s, never tested in humans. Companies hid it behind the label "Acacia rigidula extract." The FDA tested 21 supplements claiming Acacia rigidula on the label — 52% contained BMPEA. The plant doesn't produce the compound. Consumers following recommended dosing ingested up to 93.7mg per day of an untested amphetamine analogue they thought was a plant extract.

Prescription drug withdrawn 2010. Originally sold as Meridia. A clinical trial found a 16% increased risk of heart attack, stroke, and cardiovascular death. Abbott Laboratories pulled it from the market. It is now the most commonly found hidden drug in weight loss supplements. Hundreds of "herbal" and "all-natural" products contain undeclared sibutramine. The FDA's tainted supplement database lists them. New ones appear regularly.

Recalled 2009. One of the best-selling weight loss supplements in American history. The FDA received 23 reports of serious liver injuries, including one death and multiple liver transplants. The FDA couldn't determine which specific ingredient caused the damage because the product used proprietary blends of undisclosed quantities — a direct consequence of supplement labeling loopholes. The company reformulated and continued selling Hydroxycut under the same name.

Ongoing 2023–2026. Products labeled as Mexican "tejocote root" for weight loss actually contain yellow oleander — a toxic plant with cardiac glycosides that can cause fatal heart rhythm disturbances. The FDA has been updating this safety alert continuously for over two years, adding new tainted products as they find them. This is one of the FDA's most active ongoing cases.

State bans spreading, 2024–2026. A pharmaceutical antidepressant approved in some countries but never by the FDA. At high doses it acts on opioid receptors, producing euphoria and physical dependence. Sold at gas stations as "Neptune's Fix," "ZaZa Red," and "Tianaa." Poison control calls surged from 6 cases in 2014 to nearly 400 in 2023 — a 65x increase. At least 12 states have now banned it. In January 2024, Neptune's Fix products were recalled after being found to contain tianeptine AND synthetic cannabinoid receptor agonists.

FDA says not a dietary ingredient. Still available. A Soviet-era anti-anxiety drug that acts on GABA-B receptors. Causes physical dependence, severe withdrawal (anxiety, insomnia, psychosis, seizures). The FDA issued warnings in 2019. A follow-up study found that phenibut quantities increased in 3 of 4 brands after the FDA warning. The warnings had essentially no deterrent effect. Still sold online as a "nootropic."